A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo controlled, multi-center outpatient study, in
adults with GAD.
Patients 18-65 years of age, with the diagnosis of GAD according to DSM-IV criteria, who
fulfill the inclusion/exclusion criteria, will be enrolled in this study.